Clinical trials: Fluorescence Imaging

Prostate Cancer, Prostate Cancer (Adenocarcinoma)

A Single-Arm, Blinded, Fluorescent PSMA Histopathology Trial of AS1986NS

• Active, not recruiting
• Age: 18 to 90 years
• Phase 1/2
• Injection or infusion

A Single-Arm, blinded, fluorescent PSMA histopathology trial of AS1986NS

Conditions

Prostate Cancer, Prostate Cancer (Adenocarcinoma), Fluorescence Imaging

Trial name

LUMA-PSMA (NCT06906471)

Testing

AS1986NS

Where

2 sites in United States

Volunteers

15 people

Sponsor

Antelope Surgical Solutions, Inc